When Parkinson’s symptoms become difficult to manage with medication, daily activities may become more challenging. Persistent tremors, medication wearing off, and involuntary movements can affect quality of life. Advanced treatments, including deep brain stimulation, focused ultrasound, and continuous medication delivery, may help selected patients manage symptoms. Understanding eligibility, benefits, risks, and treatment differences supports informed discussions with specialists.
Parkinson’s disease affects brain circuits involved in movement. Medications such as carbidopa-levodopa help replace or compensate for reduced dopamine activity, but their effects may become less predictable as the condition changes over time.
This does not necessarily mean medication has stopped working completely. Often, the challenge is that symptom relief lasts for a shorter period, becomes inconsistent, or comes with side effects that interfere with daily activities.
Motor fluctuations describe changes in movement control throughout the day. A person may move relatively comfortably after taking medication but experience increasing stiffness, slowness, or tremor before the next dose.
Common patterns include:
Wearing-off episodes: Symptoms return before the next scheduled dose.
Off periods: Medication provides insufficient movement control for a period of time.
Dyskinesia: Involuntary movements that can occur during medication treatment.
Unpredictable movement changes: Medication response varies despite following the prescribed schedule.
These symptoms may prompt a review of medication timing, dosage, formulation, or additional medicines. If adjustments do not provide adequate control, advanced treatment options may become relevant.
Advanced treatment does not necessarily mean surgery. Several approaches can help when conventional medication schedules become difficult to manage.
The most appropriate option depends on the symptoms that cause the greatest difficulty, how well symptoms respond to levodopa, medical history, cognitive function, and personal preferences.
Deep brain stimulation is a surgical treatment that uses implanted electrodes to deliver electrical signals to specific brain regions involved in movement. The electrodes connect to a device, typically implanted under the skin near the chest, that controls stimulation.
DBS can help manage selected movement symptoms, including tremor, stiffness, slowness, dyskinesia, and medication-related motor fluctuations. It is not a cure for Parkinson’s disease and does not stop the underlying disease from progressing. Medication may still be necessary after surgery.
Focused ultrasound uses concentrated sound waves, guided by MRI, to create a small, targeted lesion in a brain region involved in movement. Unlike DBS, the procedure does not require implanted electrodes or a stimulation device.
It may be considered for selected patients with medication-resistant tremor or other specific movement symptoms, depending on the treatment target and applicable approval.
The distinction is important: focused ultrasound creates a permanent change in brain tissue, whereas DBS delivers adjustable electrical stimulation. Neither approach is appropriate for every person with Parkinson’s disease.
Some advanced Parkinson’s treatments deliver medication continuously rather than relying entirely on separate oral doses. Options may include pump-based therapies using formulations of Parkinson’s medication.
These approaches may be considered when fluctuations persist despite medication adjustments. They have their own requirements, potential side effects, equipment or administration demands, and eligibility considerations.
For some people, optimizing medication or using a continuous delivery system may be appropriate before considering brain surgery. The options are not necessarily mutually exclusive over the course of treatment.
Being diagnosed with Parkinson’s disease does not automatically make someone eligible for DBS or focused ultrasound. Each procedure has different selection criteria, and eligibility must be assessed by a qualified medical team.
DBS is often considered when movement symptoms significantly affect quality of life despite appropriate medication management. Factors that may support referral include:
Persistent tremor that interferes with daily activities.
Significant wearing-off episodes or other motor fluctuations.
Troublesome dyskinesia associated with medication.
A meaningful response to levodopa, even if that response does not last long enough.
Overall health and ability to undergo surgery and follow-up care.
A person does not necessarily need to wait until medication becomes completely ineffective. In fact, DBS may be useful when medication still improves movement but its effects are inconsistent or accompanied by difficult side effects.
A comprehensive evaluation may include a review of symptoms and medication history, neurological examinations, imaging, and testing of memory and thinking. A levodopa challenge may help clinicians assess how much movement improves with medication.
Cognitive impairment, significant psychiatric symptoms, balance difficulties, other medical conditions, and surgical risks can affect whether DBS is suitable. Age alone does not determine eligibility, although overall health and individual circumstances matter.
Focused ultrasound has its own eligibility requirements, including considerations related to the intended treatment target, symptoms, imaging, and procedural safety.
A specialist evaluation is more informative than relying on a single symptom or a checklist to determine whether surgery is appropriate.
Both DBS and focused ultrasound target brain circuits involved in movement, but they work differently. The choice depends on the symptoms being treated, the person's medical circumstances, the risks they are willing to accept, and the likely benefits of each approach.
|
Feature |
Deep brain stimulation |
Focused ultrasound |
|---|---|---|
|
Procedure |
Electrodes implanted in targeted brain regions |
Concentrated ultrasound creates a targeted lesion |
|
Implanted device |
Yes |
No |
|
Adjustability |
Stimulation settings can be changed |
The lesion itself is permanent |
|
Treatment approach |
Can treat one or both sides, as clinically appropriate |
Treatment options depend on the approved procedure and target |
|
Follow-up |
Device programming and ongoing clinical care |
Clinical follow-up and monitoring |
|
Potential limitations |
Surgery, device maintenance, stimulation-related side effects |
Permanent tissue change and possible lasting side effects |
DBS may offer flexibility because clinicians can adjust stimulation settings as symptoms and treatment needs change. However, it requires implanted hardware and ongoing device management.
Focused ultrasound avoids implanted hardware, but the treatment effect cannot be reversed simply by changing a setting. A lesion can also produce side effects that may persist.
Focused ultrasound approvals and indications have expanded over time. The US Parkinson’s Foundation reports FDA approvals for Parkinson’s-related treatment targets and a 2025 expansion permitting treatment on both sides of the brain under specified conditions, with procedures separated by at least six months. The exact indication and eligibility should be verified with the treating center.
Advanced treatment can improve selected symptoms, but no procedure is risk-free. A discussion of potential benefits should include possible complications, recovery, follow-up, and symptoms that may not improve.
Potential complications include infection, bleeding, device problems, and adverse effects related to stimulation. Depending on the brain target and settings, some people may experience speech changes, balance difficulties, muscle contractions, mood changes, or other effects.
DBS may improve tremor and motor fluctuations without resolving every Parkinson’s symptom. Problems involving cognition, speech, posture, freezing, or balance may respond less consistently. Results vary by individual and symptom type.
Potential side effects include headache, dizziness, nausea, numbness or tingling, weakness, and changes in walking, balance, speech, or swallowing. Some effects may be temporary, while others can persist. Serious complications, although less common, can also occur.
Because focused ultrasound creates a permanent lesion, the potential consequences of an unwanted effect need careful consideration. The risk profile also depends on the treatment target and whether one or both sides of the brain are treated.
Patients should ask the treatment team which symptoms are most likely to improve, which may remain unchanged, and what the center's follow-up process involves.
Motor fluctuations do not automatically mean surgery is the next step. A movement disorder specialist may first review the timing of symptoms, medication response, meal patterns, and possible side effects.
Depending on the person's situation, adjustments may include changes to levodopa timing or formulation, additional medications, or continuous medication delivery.
A symptom diary can help identify patterns that may not be obvious during a short office visit. Useful details include:
The time each medication dose is taken.
When movement improves after a dose.
When tremor, stiffness, or slowness returns.
When dyskinesia occurs.
Whether meals, sleep, or daily activities appear to affect symptom timing.
This information can help clinicians distinguish wearing-off episodes from other movement problems and evaluate whether medication changes are providing adequate control.
Before considering an advanced treatment, identify the specific daily difficulties that matter most. For example, one person may want better control of a disabling tremor, while another may be more concerned about prolonged off periods or involuntary movements.
Clear goals make it easier to assess whether a procedure or medication strategy is likely to address the problem. They also help establish realistic expectations about symptoms that may remain after treatment.
The financial implications of advanced Parkinson’s treatment can extend beyond the procedure itself. Total expenses may include specialist consultations, diagnostic testing, the procedure or device, hospital services, programming appointments, rehabilitation, and ongoing medication.
Actual out-of-pocket costs depend on the treatment center, insurance coverage, medical necessity requirements, and individual benefit arrangements. There is no single cost that applies to every patient.
Before proceeding, ask the treatment center and insurer about:
Coverage for the procedure and related services.
Prior authorization and referral requirements.
Surgeon, hospital, and specialist fees.
Device and follow-up programming costs for DBS.
Post-procedure rehabilitation and transportation.
Expected medication needs and long-term follow-up expenses.
When comparing providers, consider their experience with Parkinson’s procedures, the availability of movement disorder neurologists and neurosurgeons, the evaluation process, and how complications or follow-up needs are managed.
A center that offers both DBS and focused ultrasound may be able to discuss their relative suitability for an individual's symptoms. However, treatment availability alone does not establish that either procedure is appropriate.
When Parkinson’s medication no longer provides reliable symptom control, the next step is to identify why symptoms are changing and determine which treatment options address the main problem.
A structured discussion with a movement disorder specialist should cover medication optimization, the pattern of motor fluctuations, response to levodopa, surgical eligibility, procedural risks, long-term care, and insurance considerations.
DBS, focused ultrasound, and continuous medication delivery offer different approaches to managing selected Parkinson’s symptoms. The most suitable option depends on individual clinical findings rather than a general ranking of procedures.
Preparing a medication and symptom diary, listing the daily activities most affected, and bringing questions about benefits, limitations, and costs can make the consultation more productive. The objective is to find a treatment strategy that addresses meaningful movement difficulties while accounting for safety, personal priorities, and long-term care needs.